Chromatin Bioscience's synthetic promoter supports EsoBiotec's ESO-T01 CAR-T therapy as it enters the clinic
Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...